SCHEMBL649574

SCHEMBL649574

N#Cc1cncc(N2C[C@H]3CN(C(=O)OCc4ccccc4)C[C@H]32)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRNB2 P17787 5/20 0.47
CHRNA4 P43681 5/20 0.47
CHRNB4 P30926 3/20 0.47
CHRNA3 P32297 3/20 0.47
FNTA P49354 2/20 0.44
FNTB P49356 2/20 0.44
PGGT1B P53609 2/20 0.44
L3MBTL1 Q9Y468 1/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
CHRM4 P08173 2/20 0.39
MAPT P10636 5/20 0.39
ALDH1A1 P00352 4/20 0.39
MEN1 O00255 4/20 0.39
KMT2A Q03164 4/20 0.39
GAA P10253 2/20 0.39
HPGD P15428 1/20 0.39
ALOX15 P16050 1/20 0.39
HSD17B10 Q99714 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL654606 1.00 CHRNB2 (0.47) CHRNB2CHRNA4CHRNB4CHRNA3FNTA
SCHEMBL650793 0.85 CHRNB2 (0.44) CHRNB2CHRNA4CHRNB4CHRNA3SMN1; SMN2
SCHEMBL653614 0.85 CHRNB2 (0.44) CHRNB2CHRNA4CHRNB4CHRNA3SMN1; SMN2
SCHEMBL652628 0.84 CHRNB2 (0.48) CHRNB2CHRNA4CHRNB4CHRNA3SMN1; SMN2
SCHEMBL929833 0.82 CHRNB2 (0.49) CHRNB2CHRNA4CHRNB4CHRNA3FNTA
SCHEMBL651870 0.82 GRIN2B (0.50) CHRNB2CHRNA4CHRNB4CHRNA3SMN1; SMN2
SCHEMBL651154 0.82 GRIN2B (0.50) CHRNB2CHRNA4CHRNB4CHRNA3SMN1; SMN2
SCHEMBL3582114 0.81 CHRNB2 (0.58) CHRNB2CHRNA4CHRNB4CHRNA3
SCHEMBL3583494 0.81 CHRNB2 (0.58) CHRNB2CHRNA4CHRNB4CHRNA3
SCHEMBL653364 0.79 CHRNB2 (0.51) CHRNB2CHRNA4CHRNB4CHRNA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8119635-B2 Diazabicyclic central nervous system active agents ABBOTT LABORATORIES (US) 2012-02-21 US disclosed
EP-2316836-A1 Substituted diazabicycloalkane derivatives as ligands at alpha 7 nicotinic acetylcholine receptors Abbott Laboratories (US) 2011-05-04 EP disclosed
EP-2298775-A1 Diazabicyclic central nervous system active agents Abbott Laboratories (US) 2011-03-23 EP disclosed
EP-2295437-A1 Diazabicyclic central nervous system active agents Abbott Laboratories (US) 2011-03-16 EP disclosed
US-7872010-B2 Substituted diazabicycloalkane derivatives having affinity for nicotinic acetylcholine receptors ABBOTT LABORATORIES (US) 2011-01-18 US disclosed